The protein synthesis inhibitors mycalamides A and E have limited susceptibility toward the drug efflux network - Venturi, V; Davies, C; Singh, A J; Matthews, J H; Bellows, D S; Northcote, P T; Keyzers, R A; Teesdale-Spittle, P H (J Biochem Mol Toxicol, 2012)